`Status of
`collaboration
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00217646
`
`Novartis Exhibit 2137.001
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Status of PFS Development at
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00217646
`
`Novartis Exhibit 2137.002
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Status of NVS~
`
`PFS Collaboration
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION, SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00217646
`
`Novartis Exhibit 2137.003
`Regeneron v. Novartis, IPR2021-00816
`
`
`
`Next Steps for-
`
`Collaboration
`
`CONTAINS CONFIDENTIAL BUSINESS INFORMATION , SUBJECT TO PROTECTIVE ORDER
`
`NOVITC(CH)00217646
`
`Novartis Exhibit 2137.004
`Regeneron v. Novartis, IPR2021-00816
`
`